BlackRock, Inc. 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock, Inc. BLK | 1,093,434 5.900% | 741,025 (+210.27%) | Filing |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock, Inc. BLK | 352,409 2.900% | -450,312 (-56.10%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock, Inc. BLK | 802,721 6.700% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock, Inc. BLK | 802,721 6.700% | 613,599 (+324.45%) | Filing |